Agoracom: Small Cap Investment - Zenith Epigenetics

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

Wow…

Cancundude

Sep 23, 2024 10:38AM

jonzobot

Rank: President [?]

Points: 2524 [?]

Votes: 20 Score: 3.6 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Wow…

in response to

Wow…

Cancundude

posted on Sep 23, 2024 11:59AM

Zen was looking bright. Now, Don's going double or nothing with RVX and using Zenith to cover the bet.

Reply New Message

Back To Forum List View

Please to post a reply